292 related articles for article (PubMed ID: 18344241)
1. Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.
Rüster C; Bondeva T; Franke S; Förster M; Wolf G
Nephrol Dial Transplant; 2008 Jul; 23(7):2179-91. PubMed ID: 18344241
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone-related protein induces hypertrophy in podocytes via TGF-beta(1) and p27(Kip1): implications for diabetic nephropathy.
Romero M; Ortega A; Izquierdo A; López-Luna P; Bosch RJ
Nephrol Dial Transplant; 2010 Aug; 25(8):2447-57. PubMed ID: 20200004
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin protects podocytes from damage by advanced glycation end-products.
Ruester C; Franke S; Bondeva T; Wolf G
Nephron Exp Nephrol; 2011; 117(1):e21-30. PubMed ID: 20689331
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
[TBL] [Abstract][Full Text] [Related]
5. Activation of the receptor for advanced glycation end products induces nuclear inhibitor of protein phosphatase-1 suppression.
Liebisch M; Bondeva T; Franke S; Daniel C; Amann K; Wolf G
Kidney Int; 2014 Jul; 86(1):103-17. PubMed ID: 24476693
[TBL] [Abstract][Full Text] [Related]
6. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
Baba M; Wada J; Eguchi J; Hashimoto I; Okada T; Yasuhara A; Shikata K; Kanwar YS; Makino H
J Am Soc Nephrol; 2005 Nov; 16(11):3222-34. PubMed ID: 16177004
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products suppress neuropilin-1 expression in podocytes by a reduction in Sp1-dependent transcriptional activity.
Bondeva T; Wolf G
Am J Nephrol; 2009; 30(4):336-45. PubMed ID: 19590177
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in the db/db mouse.
Loeffler I; Rüster C; Franke S; Liebisch M; Wolf G
Am J Physiol Renal Physiol; 2013 Sep; 305(6):F911-8. PubMed ID: 23825071
[TBL] [Abstract][Full Text] [Related]
10. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin-1-dependent manner.
Bondeva T; Wojciech S; Wolf G
Am J Physiol Renal Physiol; 2011 Oct; 301(4):F852-70. PubMed ID: 21734098
[TBL] [Abstract][Full Text] [Related]
12. Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes.
Chen Y; Liu CP; Xu KF; Mao XD; Lu YB; Fang L; Yang JW; Liu C
Am J Nephrol; 2008; 28(6):1014-22. PubMed ID: 18648192
[TBL] [Abstract][Full Text] [Related]
13. Oxidized LDL induces proliferation and hypertrophy in human umbilical vein endothelial cells via regulation of p27Kip1 expression: role of RhoA.
Seibold S; Schürle D; Heinloth A; Wolf G; Wagner M; Galle J
J Am Soc Nephrol; 2004 Dec; 15(12):3026-34. PubMed ID: 15579505
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycated albumin impairs protein degradation in the kidney proximal tubules cell line LLC-PK1.
Sebeková K; Schinzel R; Ling H; Simm A; Xiang G; Gekle M; Münch G; Vamvakas S; Heidland A
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1051-60. PubMed ID: 9846887
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell proliferation of Tenon's capsule fibroblast by S-phase kinase-interacting protein 2 targeting SiRNA through increasing p27 protein level.
Wang F; Qi LX; Su Y; Yan QH; Teng Y
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1475-82. PubMed ID: 19875654
[TBL] [Abstract][Full Text] [Related]
17. [Overexpression of p27(KIP1) induced by Bak gene leads to the arrest in G(1) phase of HCC-9204 cell line].
Li J; Wang W; Yu X; Yang X; Hou Y
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():27-9. PubMed ID: 11509132
[TBL] [Abstract][Full Text] [Related]
18. Ezrin contributes to impaired podocyte migration and adhesion caused by advanced glycation end products.
McRobert EA; Bach LA
Nephrology (Carlton); 2016 Jan; 21(1):13-20. PubMed ID: 26032400
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end-products suppress neuropilin-1 expression in podocytes.
Bondeva T; Rüster C; Franke S; Hammerschmid E; Klagsbrun M; Cohen CD; Wolf G
Kidney Int; 2009 Mar; 75(6):605-16. PubMed ID: 19037249
[TBL] [Abstract][Full Text] [Related]
20. High glucose and advanced glycosylated end-products affect the expression of alpha-actinin-4 in glomerular epithelial cells.
Ha TS
Nephrology (Carlton); 2006 Oct; 11(5):435-41. PubMed ID: 17014558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]